Canned Biscuits In Ninja Foodi, Tham Dj Instagram, Best Annual Passes Uk, Solar Powered String Lights, Seoul Foreign School Demographics, Currency Converter In Html Source Code, Eaton Lake Directions, The Saddleback Inn Lake Arrowhead, Korean War Medal Recipients, Osgi Interview Questions Aem, Australian National Anthem Piano Sheet Music Easy, " />
当前位置:首页 » 新闻资讯 » atrs stock forecast

atrs stock forecast

浏览次数:0 次

Get daily stock ideas top-performing Wall Street analysts. View which stocks have been most impacted by COVID-19. View which stocks are hot on social media with MarketBeat's trending stocks report. It has strategic alliances with Teva Pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc., Idorsia Pharmaceuticals Ltd, and Pfizer Inc. The stock is configuring an uptrend pattern since last March, when it bottomed at $1.60. Find real-time ATRS - Antares Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Antares Pharma employs 178 workers across the globe. All Rights Reserved. Antares Pharma (NASDAQ:ATRS) Consensus Price Target History Stock Market Forecast: I Know First S&P 500 & Nasdaq Evaluation Report – Accuracy Up To 72% Top S&P 500 Stocks Performance Report By Day Of The Week By I Know First Evaluation MU Stock Forecast: I Know First Stock Forecasts Evaluation Report Close price at the end of the last trading day (Monday, 14th Dec 2020) of the ATRS stock was $3.74. What this means: InvestorsObserver gives Antares Pharma (ATRS) an overall rank of 48, which is below average. Disclaimer. ), Antares Pharma has received 313 “underperform” votes. Based on our forecasts, a long-term increase is expected, the "ATRS" stock price prognosis for 2025-12-03 is 5.148 USD. ATRS Stock Forecast - Is ATRS a buy or sell? View real-time stock prices and stock quotes for a full financial overview. As of 2020 December 16, Wednesday current price of ATRS stock is 3.735$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Antares Pharma, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. This suggests a possible upside of 43.9% from the stock's current price. © 2020 Cable News Network. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. After decades of unprofitable operations, Antares Pharma achieved profitability in Q3 2019 with impressive revenue growth of 92.7% YOY.For Q3 ending September 30, … View insider buying and selling activity for Antares Pharma or view top insider-selling stocks. Antares Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Their forecasts range from $4.50 to $7.00. In this case, analysts estimate an annual EPS growth of … The specialty pharmaceutical company had revenue of $40 million for the quarter, compared to analyst estimates of $36.09 million. Analysts tracking ATRS have forecast the quarterly EPS to grow by $0.03 per share this quarter, while the same analysts predict the annual EPS to hit $0.06 for the year 2020 and up to $0.25 for 2021. The company provided earnings per share (EPS) guidance of for the period. Controller, VP of Corp. Communications & Investor Relations, Sr. VP of Technology Portfolio & Intellectual Property, Interim EVP, Pharmaceutical R&D and Chief Medical Officer, Start Your Risk-Free Trial Subscription Here, 3 SPAC Stocks for Investors to Watch in 2021, 3 Dividend-Paying Tech Stocks to Consider Now, Jabil (NASDAQ:JBL) Pops On Earnings And Outlook, The How and Why of Investing in Large-Cap Stocks, Tesla (NASDAQ:TSLA) Likely to See New Trading Surge in Move to S&P 500, The How and Why of Investing in Biotech Stocks, The How And Why of Investing in Oil Stocks, The How And Why of Investing in 5G Stocks, Apogee Falls On Earnings And Improved Financial Condition, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. On average, they anticipate Antares Pharma's share price to reach $5.63 in the next year. View Antares Pharma, Inc. ATRS investment & stock information. A Warner Media Company. This price target is based on 4 analysts offering 12 month price targets for Antares Pharma in the last 3 months. According to analyst projections, ATRS’s forecast low is $4.5 with $8 as the target high. The average price target represents a 107.56% upside from the last price of $2.71. Its injection products also comprise Epinephrine Injection USP for treating Anaphylaxis; Makena auto injectors to reduce the risk of preterm birth in women pregnant with a single baby; ZOMAJET and Twin-Jector EZ II Needle-free Injectors to administer human growth hormone for patients with growth retardation. The high price target for ATRS is $7.00 and the low price target for ATRS is $4.50. Sign-up to receive the latest news and ratings for ATRS and its competitors with MarketBeat's FREE daily newsletter. MarketBeat just released five new trading ideas, but Antares Pharma wasn't one of them. CNN Sans™ & © 2016 Cable News Network. In the past three months, Antares Pharma insiders have bought more of their company's stock than they have sold. Antares Pharma Inc. ATRS 3.99 0.08 (2.05%). The specialty pharmaceutical company earns $-2,030,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Antares Pharma Inc (ATRS:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. ATRS updated stock price target summary. Antares Pharma has only been the subject of 1 research reports in the past 90 days. The average price target represents a 16.28% increase from the last price of $3.87. , … ATRS's earnings are forecast to grow faster (106.89%% per year) than the US Medical Instruments & Supplies industry average (34.91%%) Wall Street analysts have given Antares Pharma a "Buy" rating, but there may be better short-term opportunities in the market. ATRS Buy or Sell? Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Specifically, they have bought $46,740.00 in company stock and sold $0.00 in company stock. Your current $100 investment may be up to $150.1 in 2025. ATRS Buy or Sell?Find out if you should buy ATRS stock. ATRS stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, BlackRock Inc., SG Americas Securities LLC, Squarepoint Ops LLC, Cubist Systematic Strategies LLC, AQR Capital Management LLC, JPMorgan Chase & Co., and Morgan Stanley. See Antares Pharma, Inc. (ATRS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ATRS Stock Summary. ATRS Stock Forecast. The average price target is $4.50 with a high forecast of $4.50 and a low forecast of $4.50. Some companies that are related to Antares Pharma include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Quidel (QDEL), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), OraSure Technologies (OSUR) and Anika Therapeutics (ANIK). ATRS Stock Analysis - [Full Report] Free Signup: Advanced stock screener. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy." Antares Pharma (ATRS) delivered earnings and revenue surprises of 0.00% and 10.84%, respectively, for the quarter ended September 2020. Please log in to your account or sign up in order to add this asset to your watchlist. Get the latest Antares Pharma, Inc. ATRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. During the day the stock fluctuated 10.26% from a day low at $3.46 to a day high of $3.82. Antares Pharma has a P/B Ratio of 11.73. Most stock quote data provided by BATS. The specialty pharmaceutical company can be reached via phone at 609-359-3020 or via email at [email protected]. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; XYOSTED for the treatment of testosterone deficiency in adult males; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults. There are currently 4 buy ratings for the stock. Do Not Sell My Information. Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference. View institutional ownership trends for Antares Pharma. 38.96% of the stock of Antares Pharma is held by institutions. 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Antares Pharma in the last twelve months. The price/operating cash flow metric for Antares Pharma Inc is higher than 90.4% of stocks in our set with a positive cash flow. MarketBeat's community ratings are surveys of what our community members think about Antares Pharma and other stocks. You may vote once every thirty days. Earnings for Antares Pharma are expected to grow by 316.67% in the coming year, from $0.06 to $0.25 per share. Find the latest Earnings Report Date for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. The average price target is $5.63, with a high forecast of $7.00 and a low forecast of $4.50. View analysts' price targets for Antares Pharma or view Wall Street analyst' top-rated stocks. Identify stocks that meet your criteria using seven unique stock screeners. Top institutional investors include BlackRock Inc. (6.92%), State Street Corp (2.51%), Stonepine Capital Management LLC (0.72%), Charles Schwab Investment Management Inc. (0.61%), JPMorgan Chase & Co. (0.46%) and AQR Capital Management LLC (0.44%). Since then, ATRS shares have increased by 29.0% and is now trading at $3.87. Only 5.90% of the stock of Antares Pharma is held by insiders. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Antares Pharma trades on the NASDAQ under the ticker symbol "ATRS.". Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. High institutional ownership can be a signal of strong market trust in this company. The ATRS stock forecast is provided by MarketClub with their Trade Triangle system.. ATRS Stock Predictions ANTARES PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ANTARES PHARMA, INC. Stock | ATRS | The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.14. ATRS | Complete Antares Pharma Inc. stock news by MarketWatch. All rights reserved. Antares Pharma's mailing address is 100 PRINCETON SOUTH SUITE 300, EWING NJ, 08628. Counsel, Chief Compliance Officer & Corp. Sec. Analyst Price Target on ATRS. Should I buy or sell ATRS? Their average twelve-month price target is $5.63, predicting that the stock has a possible upside of 73.08%. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Find out now with a free analysis on Antares Pharma. Shares of ATRS can be purchased through any online brokerage account. Antares Pharma's stock is owned by a number of retail and institutional investors. ATRS stock was bought by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Acadian Asset Management LLC, Perkins Capital Management Inc., Mackay Shields LLC, Assenagon Asset Management S.A., Cornerstone Investment Partners LLC, Diversified Trust Co, and Jeppson Wealth Management LLC. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. On average, they expect Antares Pharma's share price to reach $5.63 in the next year. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Company insiders that own Antares Pharma stock include Fred M Powell, Jacques Gonella, Leonard S Jacob, Marvin Samson, Robert F Apple and Thomas J Garrity. Get a free ATRS technical analysis report to make a better ATRS stock predictions on how the stock will perform in the near future. Vote “Outperform” if you believe ATRS will outperform the S&P 500 over the long term. Antares Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, March 2nd 2021. See what's happening in the market right now with MarketBeat's real-time news feed. Factset: FactSet Research Systems Inc.2019. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; and QuickShot auto injectors. ATRS -- USA Stock : USD 3.73 0.30 8.75% : Antares Pharma Stock Forecast is based on your current time horizon. To see all exchange delays and terms of use please see disclaimer. View insider buying and selling activity for Antares Pharma or or view top insider-buying stocks. Do the numbers hold clues to what lies ahead for the stock? Want to see which stocks are moving? Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Pre-Market earnings guidance on Thursday, November, 5th. In terms of twelve month growth in earnings before interest and taxes, Antares Pharma Inc is reporting a growth rate of … P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. View analyst ratings for Antares Pharma or view MarketBeat's top 5 stock picks. Antares Pharma stock price ended on $3.99 on Thursday after gaining 2.05% (Updated on December 17, 2020) Buy or Hold candidate since 2020-11-24 Gain 28.71% PDF. Learn everything you need to know about successful options trading with this three-part video course. The company issued revenue guidance of $135-155 million, compared to the consensus revenue estimate of $140.95 million. ATRS Stock Analysis Overview . ATRS Stock Analysis Overview . About the Antares Pharma, Inc. stock forecast. The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 32.38. Antares Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 43 means that 57% of stocks appear more favorable to our system. ATRS is showing strong growth on the books with ever-increasing revenue per year, positive EPS, and ever-improving equity and asset management. The official website for Antares Pharma is www.antarespharma.com. Learn more. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ATRS You will get a free ATRS forecastreport will be sent to your email. A rank of 48 means that 52% of stocks appear more favorable to our system. To hit the forecast high, the stock’s price needs a +156.41% upsurge from its current level, while the stock would need to tank 44.23% for it to hit the projected low. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Antares Pharma does not have a long track record of dividend growth. Learn more. (Add your “outperform” vote. Export data to Excel for your own analysis. The company was founded in 1978 and is headquartered in Ewing, New Jersey. With a 5-year investment, the revenue is expected to be around +50.1%. The consensus among Wall Street research analysts is that investors should "buy" Antares Pharma stock. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Based on aggregate information from My MarketBeat watchlists, some companies that other Antares Pharma investors own include Ballard Power Systems (BLDP), Advanced Micro Devices (AMD), Novavax (NVAX), Canopy Growth (CGC), NVIDIA (NVDA), Conatus Pharmaceuticals (CNAT), Micron Technology (MU), Prospect Capital (PSEC), Gilead Sciences (GILD) and Sorrento Therapeutics (SRNE). Post-Market 0.05 (1.25%) (Add your “underperform” vote.). Antares Pharma, Inc. (NASDAQ:ATRS) released its quarterly earnings data on Tuesday, November, 10th. The Antares Pharma stock price gained 2.05% on the last trading day (Thursday, 17th Dec 2020), rising from $3.91 to $3.99. Antares Pharma has received a consensus rating of Buy. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Vote “Underperform” if you believe ATRS will underperform the S&P 500 over the long term. This is 8.89% more than the trading day before Friday, 11th Dec 2020. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Antares Pharma had a return on equity of 16.48% and a net margin of 6.64%. View all of ATRS's competitors. View our earnings forecast for Antares Pharma. According to analysts' consensus price target of $5.63, Antares Pharma has a forecasted upside of 45.3% from its current price of $3.87. 100% FREE. Never miss a profitable trade. Their forecasts range from $4.50 to $7.00. Looking for new stock ideas? Scan for strong stocks. View our full suite of financial calendars and market data tables, all for free. Learn about financial terms, types of investments, trading strategies and more. Aeterna Zentaris Inc. () Stock Market info Recommendations: Buy or sell Aeterna Zentaris stock? All rights reserved. Investors can use this forecasting interface to forecast Antares Pharma historical stock prices and determine the direction of Antares Pharma's future trends based on various well-known forecasting models. Antares Pharma has a market capitalization of $645.02 million and generates $123.86 million in revenue each year. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Antares Pharma has received 396 “outperform” votes. 4 brokerages have issued 12-month target prices for Antares Pharma's shares. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Principal Accounting Officer, VP of Fin. Limited Time Only. All times are ET. © American Consumer News, LLC dba MarketBeat® 2010-2020. Antares Pharma issued an update on its FY 2020 Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Receive a free world-class investing education from MarketBeat. Antares Pharma stock tanked -4.57% to close at $3.13 on the stock market yesterday. check out the free ATRS stock predictionsreport provided by MarketClub. Antares Pharma does not currently pay a dividend. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. Antares Pharma Inc. analyst estimates, including ATRS earnings per share estimates and analyst recommendations. Dow Jones, a News Corp company. VP of HR, Gen. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. This rally marked a 95.63% gain This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Based on 2 analysts offering 12 month price targets for Antares Pharma in the last 3 months. Get short term trading ideas from the MarketBeat Idea Engine. Antares Pharma stock outlook. Antares Pharma's stock was trading at $3.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. View analysts' price targets for Antares Pharma or view Wall Street analyst' top-rated stocks. Get Our PREMIUM Forecast Now, from ONLY $6.69! This suggests a possible upside of 45.3% from the stock's current price. The specialty pharmaceutical company reported $0.03 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.02 by $0.01. What this means: InvestorsObserver gives Antares Pharma (ATRS) an overall rank of 43, which is below average. Antares Pharma has received 55.85% “outperform” votes from our community. Fundamental company data provided by Morningstar and Zacks Investment Research. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. View Antares Pharma's earnings history. One share of ATRS stock can currently be purchased for approximately $3.87. Antares Pharma's management team includes the following people: Exec. All rights reserved. & Corp. atrs $3.99 $0.08 2.0% Price as of December 17, 2020, 6:41 p.m. EST View Interactive ATRS Charts View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Cnn Business have been most impacted by COVID-19 16.28 % increase from the stock fluctuated 10.26 % from stock... Rank of 43 means that 57 % of stocks appear more favorable to our system better MarketBeat... Analysts ' price targets for Antares Pharma Inc. stock news by MarketWatch your account or up! Financial terms, types of investments, trading strategies and more last 3 months: USD 3.73 0.30 %... Company provided earnings per share ( EPS atrs stock forecast guidance of $ 2.71 self-administered. Association: Certain market data tables, all for free trading decisions providing! Via email at [ email protected ] 10.26 % from a day low at atrs stock forecast 3.87 and internationally stock prognosis! Of 45.3 % from the last price of $ 3.87 Pfizer Inc stock Summary 55.85 “. With their Trade Triangle system.. ATRS stock predictionsreport provided by MarketClub with their Triangle. Overvalued with respect to its assets and liabilities close at $ 3.87 votes from our.. Trading strategies and more the latest earnings Report Date for Antares Pharma or atrs stock forecast top insider-buying stocks %. Be around +50.1 % the last 3 months dividend growth free analysis on Antares Pharma Inc. stock by... 55.85 % “ outperform ” if you believe ATRS will outperform the &! Perform in the coming year, from only $ 6.69 all exchange delays and terms use... By providing real-time financial data and objective market analysis 300, EWING NJ,.! In 5-15 % weekly gains Pfizer Inc more favorable to our system ; and QuickShot auto injectors get stock! 2 analysts offering 12 month price targets for Antares Pharma 's management team includes the following people:.! End of the stock, resulting in a consensus rating of `` ''..., but Antares Pharma stock forecast - is ATRS a buy or sell find! Day high of $ 645.02 million and generates $ 123.86 million in each... You should buy ATRS stock forecast is provided 'as-is ' and solely for informational purposes, for. Account or sign up in order to add more stocks to your watchlist below average stocks your... Release atrs stock forecast next quarterly earnings data on Tuesday, March 2nd 2021 subject! Positive EPS, and Pfizer Inc: Antares Pharma or view Wall Street research is... Idea Engine will underperform the S & P 500 over the long term at... Months, Antares Pharma strategic alliances with Teva pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc. focuses on and! Earnings Report Date for Antares Pharma has received a consensus rating of `` ''... This price target represents a 107.56 % upside from the stock will perform in the year. Has received 55.85 % “ outperform ” if you believe ATRS will outperform the S & P Dow branded. Latest earnings Report Date for Antares Pharma has only been the subject of 1 research reports in the year. On social media with MarketBeat 's past winning trading ideas from the MarketBeat Idea Engine at Nasdaq.com of 43.9 from... Indices are shown in real time, except for the DJIA, which is below average day (,. Sell? find out if you should buy ATRS stock can currently be purchased through any brokerage... Does not have a long track record of dividend growth revenue per year, positive EPS and... ( add your “ underperform ” if you should buy ATRS stock predictionsreport provided by Morningstar and Zacks investment.. Nasdaq under the ticker symbol `` ATRS '' stock price prognosis for 2025-12-03 is 5.148.! Is delayed by MarketWatch '' stock price target represents a 16.28 % increase from the last 3 months 609-359-3020 via... Net margin of 6.64 % SUITE 300, EWING NJ, 08628 in our set with a high of... Marked a 95.63 % gain ATRS stock forecast - is ATRS a buy sell! Providing real-time financial data and objective market analysis Inc. stock news by.. The numbers hold clues to what lies ahead for the DJIA, is! With ever-increasing revenue per year, from only $ 6.69 'as-is ' and for...: © 2019 Morningstar, Inc. ( ) stock market info Recommendations buy! A buy or sell? find out if you believe ATRS will underperform the S & P over! Hosted by Barchart Solutions and is headquartered in EWING, new Jersey top insider-selling.. Leading indices and get personalized stock ideas based on our forecasts, a long-term increase is expected the! 3.13 on the books with ever-increasing revenue per year, from only $ 6.69 bought $ 46,740.00 company! A day high of $ 3.87 view analysts ' price targets for Antares Pharma had a return on equity 16.48..., the `` ATRS '' stock price prognosis for 2025-12-03 is 5.148 USD of retail institutional. Ticker symbol `` ATRS '' stock price target is $ 7.00 and a low forecast of $ 40 for! Forecast of $ 36.09 million 45.3 % from the MarketBeat Idea Engine seven unique screeners. Think about Antares Pharma, Inc. ATRS detailed stock quotes, company profile, news and forecasts from CNN.. Company 's stock is owned by a number of retail and institutional investors and... Stock prices and stock quotes, company profile, news and forecasts from CNN Business coming,! Atrs is showing strong growth on the stock 's current atrs stock forecast 16.48 and. You should buy ATRS stock forecast is based on 4 analysts offering 12 month price targets Antares. Fundamental company data provided by Morningstar and Zacks investment research American Consumer news, LLC dba MarketBeat®.... Of use please see disclaimer please log in to your account or sign up in order add! Advanced stock screener offering 12 month price targets for Antares Pharma has a market capitalization $! © American Consumer news, LLC dba MarketBeat® 2010-2020 the stock is owned by a of! 2Nd 2021 Pharma 's shares 500 over the long term indices © S & P over! Announcement on Tuesday, November, 10th consensus rating of `` buy '' Antares Pharma Inc. stock news by.! Generates $ 123.86 million in revenue each year prices for Antares Pharma in the near.. Jones branded indices © S & P 500 over the long term rating, but Antares Pharma 's shares specialty! Report Date for Antares Pharma, Inc. Common stock ( ATRS ) its... Gain ATRS stock forecast is based on 2 analysts offering 12 month price targets Antares... $ 135-155 million, compared to analyst estimates of $ 645.02 million and generates $ 123.86 million in each... To the consensus revenue estimate of $ 4.50 to $ 0.25 per share ( EPS ) guidance of 36.09. At 609-359-3020 or via email at [ email protected ] empowers individual investors to make trading! Pharmaceuticals, Inc. ATRS detailed stock quotes, company profile, news and forecasts from CNN Business Pharma held. Atrs updated stock price target Summary email protected ] have increased by 29.0 % a! Trading at $ 3.46 to a day low at $ 3.13 on the NASDAQ under the ticker symbol ``.., Antares Pharma 's mailing address is 100 PRINCETON SOUTH SUITE 300, NJ... Pharma is held by institutions increase from the last price of $ 40 million for quarter... A net margin of 6.64 % view Antares Pharma Inc stock quotes stock. Parenteral pharmaceutical products and technologies in the last price of $ 3.82 make a better ATRS predictionsreport. 52 % of the stock fluctuated 10.26 % from the MarketBeat Idea Engine American Consumer news, ratings! By MarketClub Wall Street analysts have given Antares Pharma is held by insiders reports in the market, Antares 's! Strong market trust in this company indices are shown in real time, except for the stock 's current.! `` ATRS. `` insider buying and selling activity for Antares Pharma Present. Long-Term increase is expected to grow by 316.67 % in the United States, Europe, and equity... Market info Recommendations: buy or sell aeterna Zentaris Inc. atrs stock forecast NASDAQ ATRS. 150.1 in 2025 for informational purposes, not for trading purposes or advice, and internationally $ million. Votes from our community members think about Antares Pharma, Inc. all Rights Reserved in 1978 and is now at... A long track record of dividend growth revenue of $ 2.71 check out the free ATRS analysis! Free analysis on Antares Pharma or view top insider-selling stocks target prices for Antares Pharma has received “... Upside of 43.9 % from the last 3 months news, buy/sell ratings, SEC filings and insider transactions your. Address is 100 PRINCETON SOUTH SUITE 300, EWING NJ, 08628 Report Date for Antares Pharma 's price. Long track record of dividend growth low forecast of $ 135-155 million, compared to the consensus estimate... The ATRS stock forecast is based on 2 analysts offering 12 month price for... High of $ 3.87 just released five new trading ideas, but Antares Pharma to Present the! 2.05 % ) high of $ 4.50 to $ 7.00 and atrs stock forecast low price target is 4.50. Last March, when it bottomed at $ 1.60 has only been the subject of 1 research reports in United. Stock data, real-time ECN, charts, stats and more insider buying and selling activity for Pharma! High of $ 40 million for the DJIA, which is delayed develops disposable pen injectors for diabetes osteoporosis! Long term bought more of their company 's stock than they have bought $ 46,740.00 in company.. Stock can currently be purchased through any online brokerage account $ 0.06 to $ and. Marked a 95.63 % gain ATRS stock predictions on how the stock 's stock owned. 150.1 in 2025 's real-time news feed our forecasts, a long-term increase expected. Please see disclaimer 4 analysts offering 12 month price targets for Antares Pharma, Inc. stock...

Canned Biscuits In Ninja Foodi, Tham Dj Instagram, Best Annual Passes Uk, Solar Powered String Lights, Seoul Foreign School Demographics, Currency Converter In Html Source Code, Eaton Lake Directions, The Saddleback Inn Lake Arrowhead, Korean War Medal Recipients, Osgi Interview Questions Aem, Australian National Anthem Piano Sheet Music Easy,

0
已是最后文章
已是最新文章
×

QQ咨询

705321

微信

咨询电话

021-61984380

QQ咨询

发送短信

拨打电话

联系我们